Volume 21, Issue 4 (7-2022)
JRUMS 2022, 21(4): 478-480 |
Back to browse issues page
Ethics code: 1
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hassanshahi J. Vaccination in Patients with Kidney Disorders in the period of Corona Disease: Point of View. JRUMS 2022; 21 (4) :478-480
URL: http://journal.rums.ac.ir/article-1-6625-en.html
URL: http://journal.rums.ac.ir/article-1-6625-en.html
Rafsanjan University of Medical Sciences
Full-Text [PDF 213 kb]
(675 Downloads)
| Abstract (HTML) (1571 Views)
Full-Text: (1596 Views)
Vaccination in Patients with Kidney Disorders in the period of Corona Disease: Point of View
Jalal Hassanshahi [1]
Mohammad Kazemi[2], Aliyeh Kazemi[3]
جF. Gandomi[4], P. sofivand[5], P. Fadaei dehcheshmeh[6]
Received: 08/06/22 Sent for Revision: 19/06/22 Received Revised Manuscript: 21/06/22 Accepted: 22/06/22
Coronavirus 2019 disease or (covid-19) is an infectious disease caused by the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It seems that due to the new waves of the covid-19 disease, it is necessary to observe the social distance and health protocols along with extensive and regular vaccination. Although vaccination can be effective in controlling the disease, both covid-19 disease and vaccination against covid-19 can be associated with the development of glomerular kidney disease. Additionally, given the increased risk of infection among immunosuppressed patients, individuals with pre-existing glomerular kidney disease may require changes in their management plan during the COVID-19 pandemic. If the vaccination and drug regimen of the kidney disorder patient is according to the standard instructions, the use of the vaccine will be effective, especially in people exposed to the corona disease.
Key words: Covid-19 disease, Acute kidney injury, Immunosuppressive drugs, Vaccination
Funding: None.
Conflict of interest: None declared.
Ethical approval: None declared.
Jalal Hassanshahi [1]
ج
Received: 08/06/22 Sent for Revision: 19/06/22 Received Revised Manuscript: 21/06/22 Accepted: 22/06/22
Coronavirus 2019 disease or (covid-19) is an infectious disease caused by the acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It seems that due to the new waves of the covid-19 disease, it is necessary to observe the social distance and health protocols along with extensive and regular vaccination. Although vaccination can be effective in controlling the disease, both covid-19 disease and vaccination against covid-19 can be associated with the development of glomerular kidney disease. Additionally, given the increased risk of infection among immunosuppressed patients, individuals with pre-existing glomerular kidney disease may require changes in their management plan during the COVID-19 pandemic. If the vaccination and drug regimen of the kidney disorder patient is according to the standard instructions, the use of the vaccine will be effective, especially in people exposed to the corona disease.
Key words: Covid-19 disease, Acute kidney injury, Immunosuppressive drugs, Vaccination
Funding: None.
Conflict of interest: None declared.
Ethical approval: None declared.
[1]- Assistant Professor of Physiology, Department of Physiology and Pharmacology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. ORCID: 0000-0003-3754-8152.
(Corresponding author) Tel: (034) 31315083, Fax: (034) 31315003, E-mail: hasanshahij@gmail.com
(Corresponding author) Tel: (034) 31315083, Fax: (034) 31315003, E-mail: hasanshahij@gmail.com
Type of Study: Research |
Subject:
Pharmacology
Received: 2022/07/14 | Accepted: 2022/07/19 | Published: 2022/07/19
Received: 2022/07/14 | Accepted: 2022/07/19 | Published: 2022/07/19
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
